157 related articles for article (PubMed ID: 21382870)
1. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
Winder T; Bohanes P; Zhang W; Yang D; Power DG; Ning Y; Gerger A; Wilson PM; Tang LH; Shah M; Lee AS; Lenz HJ
Ann Oncol; 2011 Nov; 22(11):2431-2439. PubMed ID: 21382870
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of glucose-regulated protein 78 and risk of colorectal cancer: a case-control study in southwest China.
Zhang D; Zhou B; Li Y; Wang M; Wang C; Zhou Z; Sun X
PLoS One; 2013; 8(6):e66791. PubMed ID: 23818965
[TBL] [Abstract][Full Text] [Related]
3. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of glucose-regulated protein 78 and clinical relevance of neuroblastoma: Risk and prognosis.
Zhang J; Wang J; Liu Q; Gao J; Wang Q
J Cancer Res Ther; 2016; 12(3):1178-1183. PubMed ID: 28054532
[TBL] [Abstract][Full Text] [Related]
5. The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma.
Zhu X; Zhang J; Fan W; Wang F; Yao H; Wang Z; Hou S; Tian Y; Fu W; Xie D; Zhu W; Long J; Wu L; Zheng X; Kung H; Zhou K; Lin MC; Luo H; Li D
Carcinogenesis; 2013 Jun; 34(6):1273-80. PubMed ID: 23416888
[TBL] [Abstract][Full Text] [Related]
6. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
[TBL] [Abstract][Full Text] [Related]
7. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.
Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y
Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucose regulated protein 78 (GRP78) determines colorectal cancer response to chemotherapy.
Mhaidat NM; Alzoubi KH; Almomani N; Khabour OF
Cancer Biomark; 2015; 15(2):197-203. PubMed ID: 25519021
[TBL] [Abstract][Full Text] [Related]
9. Significance of functional GRP78 polymorphisms in predicting the onset of type 2 diabetic peripheral neuropathy in Chinese population.
Jia Y; Tong Y; Min L
Neurol Res; 2015 Aug; 37(8):683-7. PubMed ID: 26005757
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
Lurje G; Husain H; Power DG; Yang D; Groshen S; Pohl A; Zhang W; Ning Y; Manegold PC; El-Khoueiry A; Iqbal S; Tang LH; Shah MA; Lenz HJ
Ann Oncol; 2010 Jan; 21(1):78-86. PubMed ID: 19622587
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.
Ogawa H; Kaira K; Takahashi K; Shimizu A; Altan B; Yoshinari D; Asao T; Oyama T
Cancer Biomark; 2017 Sep; 20(3):273-281. PubMed ID: 28854502
[TBL] [Abstract][Full Text] [Related]
12. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
13. Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population.
Liu S; Li K; Li T; Xiong X; Yao S; Chen Z; Wang C; Zhao B
DNA Cell Biol; 2013 Mar; 32(3):119-24. PubMed ID: 23402331
[TBL] [Abstract][Full Text] [Related]
14. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
15. ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.
Balcerczak E; Panczyk M; Piaskowski S; Pasz-Walczak G; Sałagacka A; Mirowski M
Int J Colorectal Dis; 2010 Oct; 25(10):1167-76. PubMed ID: 20533057
[TBL] [Abstract][Full Text] [Related]
16. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer.
Kim JG; Sohn SK; Chae YS; Moon JH; Kim SN; Kang BW; Kim GC; Lee MH; Jeon SW; Chung HY; Yu W
Jpn J Clin Oncol; 2009 Aug; 39(8):497-501. PubMed ID: 19509001
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
18. Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Winder T; Zhang W; Yang D; Ning Y; Bohanes P; Gerger A; Wilson PM; Pohl A; Mauro DJ; Langer C; Rowinsky EK; Lenz HJ
Clin Cancer Res; 2010 Nov; 16(22):5591-602. PubMed ID: 20935157
[TBL] [Abstract][Full Text] [Related]
19. The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer.
Thornton M; Aslam MA; Tweedle EM; Ang C; Campbell F; Jackson R; Costello E; Rooney PS; Vlatković N; Boyd MT
Int J Cancer; 2013 Sep; 133(6):1408-18. PubMed ID: 23456958
[TBL] [Abstract][Full Text] [Related]
20. GSK3β Polymorphisms Are Associated with Tumor Site and TNM Stage in Colorectal Cancer.
Rosales-Reynoso MA; Zepeda-López P; Saucedo-Sariñana AM; Pineda-Razo TD; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
Arch Iran Med; 2019 Aug; 22(8):453-460. PubMed ID: 31679348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
